Clinical trials enrolment key to US PET (positron emission tomography) for cancer reimbursement
This article was originally published in Clinica
Executive Summary
Medicare's administrators have agreed to pay for costly positron emission tomography (PET) scans for nearly all forms of cancer not yet covered by the health plan - as long as a participating physician enrols a patient in a clinical trial or a registry.